Compass Therapeutics (CMPX) Slides 0.24% to $0.83 – Market Overview & Peer Comparison 2026
Compass Therapeutics stock dips 0.24 % as its shares trade near a year‑low, reflecting a 54 % YTD decline in a volatile biotech market. Learn what could drive next catalyst.
- COMPASS THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read